Novartis Foundation Symposium 292 - Defining Optimal Immunotherapies for Type 1 Diabetes (Hardcover)

* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).* Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.* The book integrates information from human and animal studies.* The book considers T1D within the broader context of autoimmune disease.* The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

General

Imprint:	John Wiley & Sons
Country of origin:	United States
Release date:	June 2008
First published:	December 2008
Authors:	Novartis
Dimensions:	236 x 163 x 16mm (L x W x T)
Format:	Hardcover
Pages:	222
ISBN-13:	978-0-470-72325-8
Categories:	Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN:	0-470-72325-4
Barcode:	9780470723258

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!